At meeting held on 22 May 2020
The Board of Alembic Pharmaceuticals at its meeting held on 22 May 2020 has approved raising of funds upto Rs 1200 crore by way of issue of equity shares / other securities convertible into equity shares through Qualified Institutions Placement, as may be required by the Company from time to time. The fund raising is subject to necessary permissions and approvals (including shareholders' approval and such other statutory approvals as may be required) and the provisions of applicable law.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content